Daiwa Securities Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.07M | Buy |
|
|||||
|
2025
Q2 | $4.22M | Buy |
|
|||||
|
2025
Q1 | $3.48M | Buy |
|
|||||
|
2024
Q4 | $2.95M | Buy |
|
|||||
|
2024
Q3 | $3.32M | Buy |
|
|||||
|
2024
Q2 | $2.74M | Buy |
|
|||||
|
2024
Q1 | $1.63M | Buy |
|
|||||
|
2023
Q4 | $2.07M | Buy |
|
|||||
|
2023
Q3 | $1.84M | Sell |
|
|||||
|
2023
Q2 | $2M | Buy |
|
|||||
|
2023
Q1 | $2.09M | Buy |
|
|||||
|
2022
Q4 | $2.34M | Sell |
|
|||||
|
2022
Q3 | $2.25M | Buy |
|
|||||
|
2022
Q2 | $1.35M | Buy |
|
|||||
|
2022
Q1 | $1.46M | Buy |
|
|||||
|
2021
Q4 | $1.43M | Sell |
|
|||||
|
2021
Q3 | $1.6M | Buy |
|
|||||
|
2021
Q2 | $983K | Sell |
|
|||||
|
2021
Q1 | $1.1M | Buy |
|
|||||
|
2020
Q4 | $704K | Sell |
|
|||||
|
2020
Q3 | $852K | Buy |
|
|||||
|
2020
Q2 | $585K | Hold |
|
|||||
|
2020
Q1 | $585K | Hold |
|
|||||
|
2019
Q4 | $619K | Sell |
|
|||||
|
2019
Q3 | $439K | Buy |
|
|||||
|
2019
Q2 | $276K | Hold |
|
|||||
|
2019
Q1 | $356K | Buy |
|
|||||
|
2018
Q4 | $275K | Buy |
|
|||||
|
2018
Q3 | $300K | Hold |
|
|||||
|
2018
Q2 | $338K | Hold |
|
|||||
|
2018
Q1 | $408K | Buy |
|
|||||
|
2017
Q4 | $343K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $122K | Hold |
|
|||||
|
2016
Q2 | $100K | Hold |
|
|||||
|
2016
Q1 | $113K | Buy |
|
|||||
|
2015
Q4 | $151K | Hold |
|
|||||
|
2015
Q3 | $129K | Buy |
|
|||||
|
2015
Q2 | $144K | Buy |
|